Cover Image
市場調查報告書

Doxofylline的中國市場分析 (2010∼2019年)

Investigation Report on China Doxofylline Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332770
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Doxofylline的中國市場分析 (2010∼2019年) Investigation Report on China Doxofylline Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

Doxofylline是支氣管氣喘的治療藥 (抗支氣管痙攣劑) 的一種,1988年義大利開始上市。1992年也在中國上市,現在已有提供各種劑型 (糖漿,藥丸,注射藥,API (原料藥) 及其他) 。中國國內Doxofylline的市場規模,在2010年為1億2400萬人民幣,2014年2億2400萬人民幣,2010∼2014年的年複合成長率(CAGR) 達到了15.9%。

本報告提供中國的Doxofylline的市場相關分析,提供您整體市場規模和國內價格趨勢,各企業·不同投藥形態的市場佔有率,主要製造商簡介,未來性的市場趨勢預測等調查評估。

第1章 Doxofylline的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Doxofylline市場概況

  • 中國國內的Doxofylline專利的申請·認證情形
  • 主要製造商
  • 市場規模

第3章 Doxofylline銷售情形分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 中國的Doxofylline市場:主要廠商的市場佔有率分析 (過去5年份)

  • 市場佔有率 (以銷售額為準)
  • 市場佔有率 (以銷售量為準)

第5章 中國的Doxofylline市場:各劑型分析 (過去5年份)

  • 各劑型的市場佔有率 (以銷售額為準)
  • 各劑型的市場佔有率 (以銷售量為準)

第6章 Doxofylline的醫院用標準價格

  • Shanghai Kai Bao Pharmaceutical Co., Ltd
  • Shandong Qidu Pharmaceutical Co., Ltd
  • ReYoung Pharmaceutical Co., Ltd
  • Kaifeng Canon Pharmaceutical Co., Ltd
  • Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
  • Southwast Pharmaceutical Co., Ltd
  • Xi'an Bosen BioPharma Co., Ltd
  • Fuhe Huaxing Pharmaceutical Shares Co., Ltd

第7章 中國國內的Doxofylline的主要製造商

  • Fuhe Huaxing Pharmaceutical Shares Co., Ltd
  • Xi'an Bosen BioPharma Co., Ltd
  • Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
  • Kaifeng Canon Pharmaceutical Co., Ltd
  • ReYoung Pharmaceutical Co., Ltd

第8章 中國的Doxofylline市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境預測

圖表一覽

目錄
Product Code: 1506214

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma. The situation is more serious in industrialized countries and regions where tobacco consumption is high with 5% of adults and 20% of children there having been attacked by this disease. Nearly 300 million people in China contract respiratory ailments, among which over 50 million suffer from cough with an annual growth rate of 4% and 15-20 million asthma.

Doxofylline, a derivative of theophylline, is a methylxanthine anti-bronchospasm drug for the treatment of bronchial asthma, panting chronic bronchitis and breathing difficulties caused by other bronchospasm. It is also a common drug for acute and chronic obstructive airway disorders. Unlike other methylxanthines, dexofylline has no side effects on gastrointestinal tract, nervous system, heart and kidney. First developed and marketed by ITALY and ABC company in 1988, doxofylline has now become the best-selling drug in many countries like the US, Japan, Ireland and Canada. Chinese enterprises begun manufacturing improvements in 1992 and has now developed such dosage forms as syrup, tablet, injection and APIs. Compared with traditional theophylline and aminophylline, doxofylline has better efficacy and less toxicity and therefore is worthwhile for spreading in clinical practice.

Doxofylline develops fast after entering China, annual sales value rising from CNY 124 million in 2010 to CNY 224 million in 2014 and CAGR reaching up to 15.9% during the period of 2010-2014. Doxofylline enjoys a vast demand in China. Currently, Fuhe Huaxing Pharmaceutical Shares Co., Ltd, Xi'an Bosen BioPharma Co., Ltd, Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma, Kaifeng Canon Pharmaceutical Co., Ltd and ReYoung Pharmaceutical Co., Ltd all take up certain shares in the market, among which Fuhe Huaxing Pharmaceutical Shares Co., Ltd has the largest market share of 27.8% with sales value in 2014 reaching up to CNY 62.33 million.

As environmental pollution worsens in China, the incidence of respiratory ailments will keep growing. Therefore, the market size of doxofylline in China is expected to keep expand in the next few years.

Readers can get at least the following information from this report:

  • market size of doxofylline in China
  • market share of manufacturers of doxofylline in China
  • price of doxofylline in Chinese market
  • major manufacturers of doxofylline in Chinese market
  • market outlook of doxofylline in China

The author suggests the following groups of people purchase this report:

  • manufacturers of respiratory drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Doxofylline

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Doxofylline in China

  • 2.1. Patent and Approval Status of Doxofylline in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Doxofylline in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Doxofylline in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Doxofylline in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Doxofylline in Chinese Hospitals in 2014

  • 6.1. Shanghai Kai Bao Pharmaceutical Co., Ltd
  • 6.2. Shandong Qidu Pharmaceutical Co., Ltd
  • 6.3. ReYoung Pharmaceutical Co., Ltd
  • 6.4. Kaifeng Canon Pharmaceutical Co., Ltd
  • 6.5. Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
  • 6.6. Southwast Pharmaceutical Co., Ltd
  • 6.7. Xi'an Bosen BioPharma Co., Ltd
  • 6.8. Fuhe Huaxing Pharmaceutical Shares Co., Ltd

7. Major Manufacturers of Doxofylline in Chinese Market, 2010-2014

  • 7.1. Fuhe Huaxing Pharmaceutical Shares Co., Ltd
  • 7.2. Xi'an Bosen BioPharma Co., Ltd
  • 7.3. Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma
  • 7.4. Kaifeng Canon Pharmaceutical Co., Ltd
  • 7.5. ReYoung Pharmaceutical Co., Ltd

8. Market Outlook of Doxofylline in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Doxofylline in China
  • Chart Approval Information of Doxofylline in China
  • Chart Sales Status of Doxofylline in China, 2010-2014
  • Chart Sales Value of Doxofylline in China, 2010-2014
  • Chart Sales Value of Doxofylline in Some Regions in China, 2010-2014
  • Chart Sales Volume of Doxofylline in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Doxofylline for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Made by Fuhe Huaxing in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Made by ReYoung in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Made by Kaifeng Canon in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Made by Xi'an Bosen BioPharma in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Injections in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Tablets in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Capsules in China, 2010-2014
  • Chart Sales Value and Market Share of Doxofylline Granules in China, 2010-2014
  • Chart Price of Doxofylline Made by Shanghai Kai Bao Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Doxofylline Made by Shandong Qidu Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Doxofylline Made by ReYoung Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Doxofylline Made by Kaifeng Canon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Doxofylline Made by Zhejiang Hansheng Pharmaceutical Co., Ltd of Beisheng Pharma in Some Chinese Cities in 2014
  • Chart Price of Doxofylline Made by Southwast Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top